Microdosing uses sub-perceptual amounts — typically about 0.05-0.3g of dried Psilocybe cubensis — taken while going about normal daily activities, without any noticeable "high" or visual effects. A full dose (roughly 1g and up, commonly 2-3.5g for a strong psychedelic experience) produces clear perceptual, cognitive, and emotional alterations lasting several hours and requires a dedicated, safe setting rather than routine daily function.
Microdosing: Below the Threshold of Perception
A microdose is defined by being below the threshold of noticeable perceptual change — generally 0.05-0.3g of dried P. cubensis, or roughly 1-3mg of psilocybin. At a true microdose, there should be no visual distortion, no impairment of coordination, and no sense of being intoxicated; the goal is to remain fully functional at work, school, or other normal activities while potentially experiencing subtle shifts in mood, focus, or creative thinking. Common protocols include dosing once every three days (popularized by researcher James Fadiman) or four days on, three days off (the Stamets protocol), specifically to avoid tolerance buildup and to make the practice sustainable over weeks or months.
Full Dose: A Dedicated Psychedelic Experience
A full dose begins where perceptible effects start to appear — around 0.5-1g as a mild "museum dose" — and extends through 1-2g (clear psychedelic effects), 2-3.5g (a moderate to strong experience with significant visual and cognitive alteration), and 3.5g and up (high to "heroic" doses associated with ego dissolution and mystical-type experiences). A full dose produces effects lasting roughly 4-6 hours and requires setting aside dedicated time in a safe, prepared setting — it is not compatible with work, driving, or other responsibilities during that window.
Key Practical Differences
- Function: Microdosing is designed to be invisible in daily life; a full dose takes you out of ordinary function for hours.
- Setting requirements: Microdosing needs no special environment; full doses require a safe, prepared setting and ideally a sober support person.
- Evidence base: Full-dose effects are well documented in both clinical research and long historical use; microdosing's benefits are still supported mostly by self-report and early-stage clinical trials, with expectation effects a known confound.
- Tolerance management: Microdosing relies on structured on/off schedules to remain sub-perceptual over time; full-dose users typically space sessions weeks to months apart to let tolerance fully reset.